Gentamicin

Catalog No.S6289

For research use only.

Gentamicin is a widely used antibiotic in the intensive care unit (ICU). Gentamicin, an aminoglycoside, is an inhibitor of protein synthesis.

CAS No. 1403-66-3

Selleck's Gentamicin has been cited by 1 Publication

Purity & Quality Control

Related Other Products

Biological Activity

Description Gentamicin is a widely used antibiotic in the intensive care unit (ICU). Gentamicin, an aminoglycoside, is an inhibitor of protein synthesis.

Protocol (from reference)

Chemical Information

Molecular Weight
Formula
CAS No. 1403-66-3
Storage 3 years -20°C powder
2 years -80°C in solvent

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04775238 Recruiting Other: Silver nanoparticles|Other: Copper nanoparticles Nosocomial Infections Sohag University February 27 2021 Not Applicable
NCT04644627 Recruiting Drug: Gentamicin Sulfate Epidermolysis Bullosa Oslo University Hospital December 1 2020 Phase 1|Phase 2
NCT04505748 Completed Device: Self-transfusion device Arthroplasty Complications|Total Knee Arthroplasty University Hospital Alexandroupolis|Democritus University of Thrace January 1 2020 Not Applicable
NCT03845790 Recruiting Other: Blood and microdialysis samples Surgical Site Infection Poitiers University Hospital May 26 2019 Phase 1
NCT03632109 Terminated Drug: gentamicin 360mg IM Pharyngeal Gonococcal Infection University of Washington|National Institute of Allergy and Infectious Diseases (NIAID) September 17 2018 Phase 2|Phase 3

(data from https://clinicaltrials.gov, updated on 2022-01-17)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Gentamicin | Gentamicin supplier | purchase Gentamicin | Gentamicin cost | Gentamicin manufacturer | order Gentamicin | Gentamicin distributor